Managing the Refractory Idiopathic Overactive Bladder with OnabotulinumtoxinA: Phase 2 Trial

被引：0
|
作者：
Boone T.B. [1 ]
机构：
[1] Department of Urology, The Methodist Hospital, Methodist Neurological Institute, Houston, TX, 77030, 6560 Fannin
来源：
Current Bladder Dysfunction Reports | 2011年 / 6卷 / 2期
关键词：
Botulinum Toxin; Detrusor Overactivity; Anticholinergic Medication; onabotulinumtoxinA; Urinary Urgency Incontinence;
D O I：
10.1007/s11884-011-0082-y
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：65 / 66
页数：1
相关论文
共 50 条
  • [1] Cost Effectiveness of Sacral Neuromodulation and OnabotulinumtoxinA in Managing Refractory Idiopathic Overactive Bladder
    Tay, Li June
    Harry, Deepak
    Malde, Sachin
    Sahai, Arun
    UROLOGY, 2021, 149 : 1 - 10
  • [2] The satisfaction of patients with refractory idiopathic overactive bladder with onabotulinumtoxinA and augmentation cystoplasty
    El-Azab, Ahmed S.
    Moeen, Ahmed M.
    ARAB JOURNAL OF UROLOGY, 2013, 11 (04) : 344 - 349
  • [3] ONABOTULINUMTOXINA IMPROVES IDIOPATHIC OVERACTIVE BLADDER SYMPTOMS IN PATIENTS REFRACTORY TO ORAL MEDICATIONS
    Farrelly, Elisabeth Carlsson
    Lorenzo-Gomez, Maria-Fernando
    Schulte-Baukloh, Heinrich
    Nelson, Mariana
    Hamid, Rizwan
    JOURNAL OF UROLOGY, 2022, 207 (05): : E222 - E222
  • [4] OnabotulinumtoxinA Improves Idiopathic Overactive Bladder Symptoms in Patients Refractory to Oral Medications
    Farrelly, Elisabeth
    Lorenzo-Gomez, Maria-Fernando
    Schulte-Baukloh, Heinrich
    Nelson, Mariana
    Hamid, Rizwan
    TOXICON, 2022, 214 : S62 - S62
  • [5] Treatment of refractory overactive bladder with OnabotulinumtoxinA vs PTNS: TROOP trial
    Katelyn Smithling Kopcsay
    Tara Doyle Marczak
    Peter C. Jeppson
    Anne P. Cameron
    Rose Khavari
    Eshetu Tefera
    Robert E. Gutman
    International Urogynecology Journal, 2022, 33 : 851 - 860
  • [6] OnabotulinumtoxinA Improves Idiopathic Overactive Bladder Symptoms in Patients Refractory to Oral Medications
    Farrelly, E.
    Lorenzo-Gomez, M.
    Schulte-Baukloh, H.
    Nelson, M.
    Hamid, R.
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2022, 33 (SUPPL 2) : S408 - S409
  • [7] Treatment of refractory overactive bladder with OnabotulinumtoxinA vs PTNS: TROOP trial
    Kopcsay, Katelyn Smithling
    Marczak, Tara Doyle
    Jeppson, Peter C.
    Cameron, Anne P.
    Khavari, Rose
    Tefera, Eshetu
    Gutman, Robert E.
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2022, 33 (04) : 851 - 860
  • [8] SACRAL NEUROMODULATION VERSUS ONABOTULINUMTOXINA FOR REFRACTORY OVERACTIVE BLADDER
    Amundsen, Cindy L.
    Richter, Holly E.
    Menefee, Shawn A.
    Komesu, Yuko M.
    Arya, Lily A.
    Gregory, W. Thomas
    Myers, Deborah L.
    Zyczynski, Halina M.
    Vasavada, Sandip
    Nolen, Tracy L.
    Wallace, Dennis
    Meikle, Susan F.
    JOURNAL OF UROLOGY, 2016, 195 (04): : E949 - E950
  • [9] OnabotulinumtoxinA is Preferred over Sacral Neuromodulation for Refractory Overactive Bladder
    Siegel, Steven
    JOURNAL OF UROLOGY, 2017, 197 (01): : 11 - 12
  • [10] Injection Site Number and Outcomes of Intradetrusor OnabotulinumtoxinA for Refractory Overactive Bladder: A Randomized Clinical Trial
    Zdroik, A.
    El Haraki, A.
    Smith, W.
    Badlani, G.
    Evans, R.
    Parker-autry, C.
    Matthews, C.
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2023, 34 : S27 - S28
12345